Results 161 to 170 of about 13,497 (214)

Skeletal Muscle Mass and Body Weight Fall Proportionally With Use of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Tirzepatide: Case Report and Review of Literature. [PDF]

AACE Clin Case Rep
Zinn J, Poretsky L.
europepmc   +1 more source

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update. [PDF]

Endocrinol Metab (Seoul)
Jakubowska A, Roux CWL, Viljoen A.
europepmc   +1 more source

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis. [PDF]

Addiction
Qeadan F, McCunn A, Tingey B.
europepmc   +1 more source

A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide. [PDF]

Cureus
Le TTB, Minh LHN, Devi P, Islam N, Sachmechi I.   +4 more
europepmc   +1 more source

Evaluating glucose-dependent insulinotropic polypeptide and glucagon as key regulators of insulin secretion in the pancreatic islet.

Am J Physiol Endocrinol Metab
Lewandowski SL, El K, Campbell JE.
europepmc   +1 more source

Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease. [PDF]

Med Princ Pract
Al-Sabah S, Al-Khairi I, Jamal M, Jamal M, Qaddoumi M, Alajmi F, Kumar J, Abukhalaf N, Cherian P, Madhu D, Arefanian H, Dsouza C, Alam-Eldin N, AlSabagh A, Al Madhoun A, Al-Sabah S, Al-Mulla F, Abu-Farha M, Abubaker J.   +18 more
europepmc   +1 more source

Expression of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in the rat submandibular gland is influenced by pre- and post-natal high-fat diet exposure. [PDF]

Front Physiol
Sangsuriyothai P, Watari I, Serirukchutarungsee S, Satrawaha S, Podyma-Inoue KA, Ono T.   +5 more
europepmc   +1 more source

Cellular mechanisms governing glucose-dependent insulinotropic polypeptide secretion [PDF]

Peptides, 2020
Glucose-dependent insulinotropic polypeptide (GIP) is a gut hormone secreted from the upper small intestine, which plays an important physiological role in the control of glucose metabolism through its incretin action to enhance glucose-dependent insulin secretion. GIP has also been implicated in postprandial lipid homeostasis.
Frank Reimann, Fiona M Gribble, Daryl Hodge   +2 more
exaly   +4 more sources